A client who has increased intracranial pressure is receiving mannitol (Osmitrol). Which of the following findings should the nurse report to the provider?

Furosemide is a sulfonamide-derived loop diuretic that inhibits the Na+/K+/2Cl- symporter in the thick ascending limb. It induces potent natriuresis to alleviate acute pulmonary edema and systemic fluid volume overload. Successful therapy reduces pulmonary hydrostatic pressure, thereby resolving dyspnea, orthopnea, and crackles. Toxicity risks include ototoxicity and severe electrolyte depletion, specifically potassium levels < 3.5 mEq/L.

Rationale for correct answer

B. Effective diuresis reduces pulmonary vascular congestion by decreasing intravascular volume and preload. This physiological shift improves alveolar gas exchange and reduces the work of breathing. A reduction in the respiratory rate toward the normal range of 12 to 20 breaths/min indicates clinical stabilization. Increased tidal volume depth confirms improved pulmonary compliance following fluid mobilization.

Rationale for incorrect answers

A. A decreased level of consciousness often signals worsening cerebral hypoxia or metabolic disturbances such as hyponatremia. It is not a therapeutic goal and may indicate poor perfusion to the central nervous system. Sleeping more could be a sign of extreme fatigue or impending hypercapnic respiratory failure. The nurse must monitor for acute mental status changes as a negative outcome.

C. Increased congestion and subjective complaints of dyspnea indicate that the medication has failed to achieve fluid mobilization. These findings represent a worsening of heart failure and potential progression toward respiratory arrest. Shortness of breath suggests that hydrostatic pressure in the pulmonary capillaries remains pathologically high. The nurse should anticipate escalating the dose or adding adjunctive therapy immediately.

D. An output of 50 mL over 4 hours averages only 12.5 mL/hour, which is significantly below the minimum renal threshold of 30 mL/hour. This oliguric state, especially with a 200 mL intake, suggests treatment failure or acute kidney injury. A favorable response requires a significant net loss where output exceeds intake. The nurse must assess for catheter patency or worsening renal perfusion.

Test-taking strategy

• Identify the therapeutic goal: The question asks for a "favorable response" to a loop diuretic in a heart failure patient. Diuretics are given to remove excess fluid from the lungs and body.
• Prioritize the ABCs:
  • Airway and Breathing are the top priorities in heart failure.
  • A favorable response must show improved respiratory status.
  • Option 2 shows a decreased respiratory rate (moving toward normal) and better depth, which are direct indicators of improved oxygenation.
• Evaluate fluid balance:
  • A diuretic should cause output to be greater than intake.
  • In option 4, the intake (200 mL) is four times the output (50 mL), indicating fluid retention rather than diuresis.
• Eliminate neurological decline:
  • Option 1 describes a decline in consciousness, which is never a favorable sign for any cardiovascular or respiratory medication.
• Recognize clinical worsening:
  • Option 3 describes worsening physical assessment findings (increased congestion), which is the opposite of the drug's intended effect.

Take home points

• A primary indicator of furosemide efficacy in heart failure is the resolution of respiratory distress and the clearing of lung sounds.
• Successful diuresis is characterized by a urine output that exceeds fluid intake, typically maintaining a minimum of 30 mL per hour.
• Nurses must monitor for signs of dehydration and hypotension, such as tachycardia or skin tenting, after high-dose administration.
• Improved exercise tolerance and a decrease in daily body weight are long-term indicators of effective diuretic management.

Chlorothiazide is a benzothiadiazide derivative that inhibits the sodium-chloride symporter within the distal convoluted tubule. This thiazide diuretic increases the delivery of sodium to the collecting duct, facilitating obligatory water loss. It is indicated for hypertension and congestive heart failure management. Common complications include hypokalemia, hyperuricemia, and sulfonamide-related hypersensitivity reactions.

Rationale for correct answer

C. Thiazides promote the renal excretion of potassium, potentially leading to serum levels below 3.5 mEq/L. Muscle cramping and profound physical weakness are hallmark clinical manifestations of hypokalemia. The patient must report these symptoms to avoid lethal cardiac dysrhythmias. This assessment is vital for maintaining neuromuscular function.

Rationale for incorrect answers

A. Increasing salt intake directly antagonizes the therapeutic goal of reducing extracellular fluid volume and blood pressure. Thiazides are intended to induce a negative sodium balance to treat edema. Encouraging high salt consumption could exacerbate fluid retention and lead to treatment failure. This advice contradicts standard cardiovascular nursing protocols.

B. While grapefruit and oranges contain vitamins, the primary dietary need for a patient on chlorothiazide is potassium. Vitamin C does not mitigate the electrolyte depletion risks inherent to this drug class. Patients should focus on potassium-rich options to prevent the metabolic disturbances associated with non-potassium-sparing agents. This instruction lacks pharmacological relevance.

D. Administering diuretics during the evening hours causes nocturia, which significantly disrupts the normal sleep-wake cycle. Chlorothiazide does not typically possess sedative properties or cause central nervous system depression leading to drowsiness. Doses should be scheduled for the morning hours to ensure patient safety and rest. This prevents nighttime fall risks.

Test-taking strategy

• Identify the drug classification: Chlorothiazide is a thiazide diuretic, which is known for its potassium-wasting effects and blood pressure reduction.
• Assess the physiological impact of the drug:
  • Diuretics remove sodium and water; therefore, recommending more salt (option 1) is illogical and counter-therapeutic.
  • Diuretics increase urination; therefore, taking them at night (option 4) is a safety and comfort error.
• Connect symptoms to electrolyte shifts: Muscle weakness and cramping (option 3) are specific, classic indicators of potassium deficiency.
• Prioritize clinical safety: In discharge teaching, the most important points relate to recognizing adverse effects that require provider intervention. While nutrition is important, identifying signs of life-threatening electrolyte imbalance like hypokalemia is a higher priority than generalized vitamin C intake (option 2).

Take home points

• Hypokalemia is a primary concern with thiazide diuretics and presents as muscle weakness, cramping, or cardiac palpitations.
• Diuretic doses should be taken in the morning to prevent nocturia and decrease the risk of falls during the night.
• Patients should monitor their daily weight and report any gain of 2 to 3 pounds within a 24-hour period.
• Thiazide diuretics are structurally related to sulfonamides and may cause cross-sensitivity in patients with sulfa allergies.